{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:51:19Z","timestamp":1777596679556,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,9,13]],"date-time":"2007-09-13T00:00:00Z","timestamp":1189641600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1007\/s10549-007-9708-3","type":"journal-article","created":{"date-parts":[[2007,9,12]],"date-time":"2007-09-12T12:04:49Z","timestamp":1189598689000},"page":"99-109","source":"Crossref","is-referenced-by-count":79,"title":["The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified"],"prefix":"10.1007","volume":"110","author":[{"given":"Wen-Feng","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan-Yan","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuang-Gui","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Zhi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-Xi","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping-Qing","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gen-Hong","family":"Di","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun-Wei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Song","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Min","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Bing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Tao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen-Zhou","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Ming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,9,13]]},"reference":[{"key":"9708_CR1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74\u2013108","journal-title":"CA Cancer J Clin"},{"key":"9708_CR2","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z","volume":"77","author":"EB Claus","year":"1996","unstructured":"Claus EB, Schildkraut JM, Thompson WD, Risch NJ (1996) The genetic attributable risk of breast and ovarian cancer. Cancer 77:2318\u20132324","journal-title":"Cancer"},{"key":"9708_CR3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","volume":"62","author":"D Ford","year":"1998","unstructured":"Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BA, Gayther SA, Zelada-Hedman M et\u00a0al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62:676\u2013689","journal-title":"The Breast Cancer Linkage Consortium. Am J Hum Genet"},{"key":"9708_CR4","first-page":"2483","volume":"86","author":"JN Weitzel","year":"1999","unstructured":"Weitzel JN (1999) Genetic cancer risk assessment. Putting it all together. Cancer 86:2483\u20132492","journal-title":"Putting it all together. Cancer"},{"key":"9708_CR5","doi-asserted-by":"crossref","unstructured":"(2003) American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 21:2397\u20132406","DOI":"10.1200\/JCO.2003.03.189"},{"key":"9708_CR6","unstructured":"Daly MB, Axilbund JE, Bryant E, Buys S, Eng C, Friedman S, Esserman LJ, Farrell CD, Ford JM, Garber JE, Jeter JM, Kohlmann W, Lynch PM, Marcom PK, Nabell LM, Offit K, Osarogiagbon RU, Pasche B, Reiser G, Sutphen R, Weitzel JN (2005) Genetic\/familial high-risk assessment: breast and ovarian, version 1.2006. National Comprehensive Cancer Network, Inc., Jenkintown"},{"key":"9708_CR7","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/humu.9083","volume":"20","author":"X Zhi","year":"2002","unstructured":"Zhi X, Szabo C, Chopin S, Suter N, Wang QS, Ostrander EA, Sinilnikova OM, Lenoir GM, Goldgar D, Shi YR (2002) BRCA1 and BRCA2 sequence variants in Chinese breast cancer families. Hum Mutat 20:474","journal-title":"Hum Mutat"},{"key":"9708_CR8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/humu.9156","volume":"22","author":"Z Hu","year":"2003","unstructured":"Hu Z, Wu J, Liu CH, Lu JS, Luo JM, Han QX, Shen ZZ, Shao ZM (2003) The analysis of BRCA1 mutations in eastern Chinese patients with early onset breast cancer and affected relatives. Hum Mutat 22:104","journal-title":"Hum Mutat"},{"issue":"Suppl 1","key":"9708_CR9","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1525-1438.2006.00311.x","volume":"16","author":"N Li","year":"2006","unstructured":"Li N, Zhang X, Cai Y, Xu X, Zhang L, Pan KF, Wu LY, Wang MR (2006) BRCA1 germline mutations in Chinese patients with hereditary breast and ovarian cancer. Int J Gynecol Cancer 16(Suppl 1):172\u2013178","journal-title":"Int J Gynecol Cancer"},{"key":"9708_CR10","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00432-006-0105-9","volume":"132","author":"CG Song","year":"2006","unstructured":"Song CG, Hu Z, Wu J, Luo JM, Shen ZZ, Huang W, Shao ZM (2006) The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancer. J Cancer Res Clin Oncol 132:617\u2013626","journal-title":"J Cancer Res Clin Oncol"},{"key":"9708_CR11","first-page":"271","volume":"58","author":"SL Neuhausen","year":"1996","unstructured":"Neuhausen SL, Mazoyer S, Friedman L, Stratton M, Offit K, Caligo A, Tomlinson G, Cannon-Albright L, Bishop T, Kelsell D, Solomon E, Weber B, Couch F, Struewing J, Tonin P, Durocher F, Narod S, Skolnick MH, Lenoir G, Serova O, Ponder B, Stoppa-Lyonnet D, Easton D, King MC, Goldgar DE (1996) Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet 58:271\u2013280","journal-title":"Am J Hum Genet"},{"key":"9708_CR12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1056\/NEJM199601183340302","volume":"334","author":"MG FitzGerald","year":"1996","unstructured":"FitzGerald MG, MacDonald DJ, Krainer M, Hoover I, O\u2019Neil E, Unsal H, Silva-Arrieto S, Finkelstein DM, Beer-Romero P, Englert C, Sgroi DC, Smith BL, Younger JW, Garber JE, Duda RB, Mayzel KA, Isselbacher KJ, Friend SH, Haber DA (1996) Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med 334:143\u2013149","journal-title":"N Engl J Med"},{"key":"9708_CR13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/B:FAME.0000026837.32470.b4","volume":"3","author":"I Gal","year":"2004","unstructured":"Gal I, Gershoni Baruch R, Haber D, Dagan E, Eisenberg-Barzilai S, Zidan J, Friedman E (2004) The 1100delAT BRCA1 and the 8765delAG BRCA2 mutations: occurrence in high-risk non-Ashkenazi Jews and haplotype comparison of Jewish and non-Jewish carriers. Fam Cancer 3:11\u201314","journal-title":"Fam Cancer"},{"key":"9708_CR14","first-page":"215","volume":"12","author":"VM Benedetti De","year":"1998","unstructured":"De Benedetti VM, Radice P, Pasini B, Stagi L, Pensotti V, Mondini P, Manoukian S, Conti A, Spatti G, Rilke F, Pierotti MA (1998) Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and\/or ovarian carcinoma patients. Mutations in brief no. 178. Online. Hum Mutat 12:215","journal-title":"Mutations in brief no. 178. Online. Hum Mutat"},{"key":"9708_CR15","unstructured":"Breast Cancer Information Core http:\/\/research.nhgri.nih.gov\/bic\/"},{"key":"9708_CR16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1158\/1055-9965.EPI-03-0196","volume":"13","author":"NM Suter","year":"2004","unstructured":"Suter NM, Ray RM, Hu YW, Lin MG, Porter P, Gao DL, Zaucha RE, Iwasaki LM, Sabacan LP, Langlois MC, Thomas DB, Ostrander EA (2004) BRCA1 and BRCA2 mutations in women from Shanghai China. Cancer Epidemiol Biomarkers Prev 13:181\u2013189","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9708_CR17","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1200\/JCO.2004.04.179","volume":"22","author":"DH Choi","year":"2004","unstructured":"Choi DH, Lee MH, Bale AE, Carter D, Haffty BG (2004) Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients. J Clin Oncol 22:1638\u20131645","journal-title":"J Clin Oncol"},{"key":"9708_CR18","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W et\u00a0al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66\u201371","journal-title":"Science"},{"key":"9708_CR19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789\u2013792","journal-title":"Nature"},{"key":"9708_CR20","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/jnci\/93.16.1215","volume":"93","author":"N Loman","year":"2001","unstructured":"Loman N, Johannsson O, Kristoffersson U, Olsson H, Borg A (2001) Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J Natl Cancer Inst 93:1215\u20131223","journal-title":"J Natl Cancer Inst"},{"key":"9708_CR21","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.294.15.1925","volume":"294","author":"R Nanda","year":"2005","unstructured":"Nanda R, Schumm LP, Cummings S, Fackenthal JD, Sveen L, Ademuyiwa F, Cobleigh M, Esserman L, Lindor NM, Neuhausen SL, Olopade OI (2005) Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA 294:1925\u20131933","journal-title":"JAMA"},{"key":"9708_CR22","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/jnci\/91.14.1241","volume":"91","author":"E Warner","year":"1999","unstructured":"Warner E, Foulkes W, Goodwin P, Meschino W, Blondal J, Paterson C, Ozcelik H, Goss P, Allingham-Hawkins D, Hamel N, Di Prospero L, Contiga V, Serruya C, Klein M, Moslehi R, Honeyford J, Liede A, Glendon G, Brunet JS, Narod S (1999) Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J Natl Cancer Inst 91:1241\u20131247","journal-title":"J Natl Cancer Inst"},{"key":"9708_CR23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/1097-0215(20010101)91:1<83::AID-IJC1013>3.0.CO;2-5","volume":"91","author":"N Ikeda","year":"2001","unstructured":"Ikeda N, Miyoshi Y, Yoneda K, Shiba E, Sekihara Y, Kinoshita M, Noguchi S (2001) Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families. Int J Cancer 91:83\u201388","journal-title":"Int J Cancer"},{"key":"9708_CR24","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1054\/bjoc.1999.0960","volume":"82","author":"JH Sng","year":"2000","unstructured":"Sng JH, Chang J, Feroze F, Rahman N, Tan W, Lim S, Lehnert M, van der Pool S, Wong J (2000) The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives. Br J Cancer 82:538\u2013542","journal-title":"Br J Cancer"},{"key":"9708_CR25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s004390050936","volume":"104","author":"SS Li","year":"1999","unstructured":"Li SS, Tseng HM, Yang TP, Liu CH, Teng SJ, Huang HW, Chen LM, Kao HW, Chen JH, Tseng JN, Chen A, Hou MF, Huang TJ, Chang HT, Mok KT, Tsai JH (1999) Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan. Hum Genet 104:201\u2013204","journal-title":"Hum Genet"},{"key":"9708_CR26","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/94.18.1358","volume":"94","author":"D Thompson","year":"2002","unstructured":"Thompson D, Easton DF (2002) Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94:1358\u20131365","journal-title":"J Natl Cancer Inst"},{"key":"9708_CR27","first-page":"692","volume":"343","author":"D Ford","year":"1994","unstructured":"Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE (1994) Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343:692\u2013695","journal-title":"Breast Cancer Linkage Consortium. Lancet"},{"key":"9708_CR28","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","volume":"94","author":"MS Brose","year":"2002","unstructured":"Brose MS, Rebbeck TR, Calzone KA, Stopfer JE, Nathanson KL, Weber BL (2002) Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst 94:1365\u20131372","journal-title":"J Natl Cancer Inst"},{"key":"9708_CR29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ng0596-117","volume":"13","author":"S Thorlacius","year":"1996","unstructured":"Thorlacius S, Olafsdottir G, Tryggvadottir L, Neuhausen S, Jonasson JG, Tavtigian SV, Tulinius H, Ogmundsdottir HM, Eyfjord JE (1996) A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 13:117\u2013119","journal-title":"Nat Genet"},{"key":"9708_CR30","doi-asserted-by":"crossref","unstructured":"(1999) Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J Natl Cancer Inst 91:1310\u20131316","DOI":"10.1093\/jnci\/91.15.1310"},{"key":"9708_CR31","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","volume":"68","author":"HA Risch","year":"2001","unstructured":"Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Kwan E, Jack E, Vesprini DJ, Kuperstein G, Abrahamson JL, Fan I, Wong B, Narod SA (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68:700\u2013710","journal-title":"Am J Hum Genet"},{"key":"9708_CR32","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/annonc\/mdh474","volume":"15","author":"J Lorenzo Bermejo","year":"2004","unstructured":"Lorenzo Bermejo J, Hemminki K (2004) Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing. Ann Oncol 15:1834\u20131841","journal-title":"Ann Oncol"},{"key":"9708_CR33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/00313020220147113","volume":"34","author":"JE Armes","year":"2002","unstructured":"Armes JE, Venter DJ (2002) The pathology of inherited breast cancer. Pathology 34:309\u2013314","journal-title":"Pathology"},{"key":"9708_CR34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3346\/jkms.2004.19.2.269","volume":"19","author":"SH Ahn","year":"2004","unstructured":"Ahn SH, Hwang UK, Kwak BS, Yoon HS, Ku BK, Kang HJ, Kim JS, Ko BK, Ko CD, Yoon KS, Cho DY, Kim JS, Son BH (2004) Prevalence of BRCA1 and BRCA2 mutations in Korean breast cancer patients. J Korean Med Sci 19:269\u2013274","journal-title":"J Korean Med Sci"},{"key":"9708_CR35","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/jnci\/91.11.943","volume":"91","author":"J Peto","year":"1999","unstructured":"Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J, Stratton MR (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91:943\u2013949","journal-title":"J Natl Cancer Inst"},{"key":"9708_CR36","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s004390100500","volume":"108","author":"B Klein","year":"2001","unstructured":"Klein B, Weirich G, Brauch H (2001) DHPLC-based germline mutation screening in the analysis of the VHL tumor suppressor gene: usefulness and limitations. Hum Genet 108:376\u2013384","journal-title":"Hum Genet"},{"key":"9708_CR37","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/humu.1130","volume":"17","author":"W Xiao","year":"2001","unstructured":"Xiao W, Oefner PJ (2001) Denaturing high-performance liquid chromatography: a review. Hum Mutat 17:439\u2013474","journal-title":"Hum Mutat"},{"key":"9708_CR38","doi-asserted-by":"crossref","first-page":"8143","DOI":"10.1158\/0008-5472.CAN-04-2467","volume":"64","author":"I Tournier","year":"2004","unstructured":"Tournier I, Paillerets BB, Sobol H, Stoppa-Lyonnet D, Lidereau R, Barrois M, Mazoyer S, Coulet F, Hardouin A, Chompret A, Lortholary A, Chappuis P, Bourdon V, Bonadona V, Maugard C, Gilbert B, Nogues C, Frebourg T, Tosi M (2004) Significant contribution of germline BRCA2 rearrangements in male breast cancer families. Cancer Res 64:8143\u20138147","journal-title":"Cancer Res"},{"key":"9708_CR39","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/ng1197-341","volume":"17","author":"A Petrij-Bosch","year":"1997","unstructured":"Petrij-Bosch A, Peelen T, van Vliet M, van Eijk R, Olmer R, Drusedau M, Hogervorst FB, Hageman S, Arts PJ, Ligtenberg MJ, Meijers-Heijboer H, Klijn JG, Vasen HF, Cornelisse CJ, van \u2018t Veer LJ, Bakker E, van Ommen GJ, Devilee P (1997) BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 17:341\u2013345","journal-title":"Nat Genet"},{"key":"9708_CR40","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/jnci\/93.16.1188","volume":"93","author":"DA Berry","year":"2001","unstructured":"Berry DA (2001) Role of population-based studies in assessing genetic cancer risk. J Natl Cancer Inst 93:1188\u20131189","journal-title":"J Natl Cancer Inst"},{"key":"9708_CR41","first-page":"189","volume":"57","author":"P Tonin","year":"1995","unstructured":"Tonin P, Serova O, Lenoir G, Lynch H, Durocher F, Simard J, Morgan K, Narod S (1995) BRCA1 mutations in Ashkenazi Jewish women. Am J Hum Genet 57:189","journal-title":"Am J Hum Genet"},{"key":"9708_CR42","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/nm1196-1179","volume":"2","author":"P Tonin","year":"1996","unstructured":"Tonin P, Weber B, Offit K, Couch F, Rebbeck TR, Neuhausen S, Godwin AK, Daly M, Wagner-Costalos J, Berman D, Grana G, Fox E, Kane MF, Kolodner RD, Krainer M, Haber DA, Struewing JP, Warner E, Rosen B, Lerman C, Peshkin B, Norton L, Serova O, Foulkes WD, Garber JE et\u00a0al (1996) Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med 2:1179\u20131183","journal-title":"Nat Med"},{"key":"9708_CR43","first-page":"486","volume":"59","author":"TI Andersen","year":"1996","unstructured":"Andersen TI, Borresen AL, Moller P (1996) A common BRCA1 mutation in Norwegian breast and ovarian cancer families? Am J Hum Genet 59:486\u2013487","journal-title":"Am J Hum Genet"},{"key":"9708_CR44","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/jnci\/91.10.882","volume":"91","author":"NL Tang","year":"1999","unstructured":"Tang NL, Pang CP, Yeo W, Choy KW, Lam PK, Suen M, Law LK, King WW, Johnson P, Hjelm M (1999) Prevalence of mutations in the BRCA1 gene among Chinese patients with breast cancer. J Natl Cancer Inst 91:882\u2013885","journal-title":"J Natl Cancer Inst"},{"key":"9708_CR45","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/1098-1004(200007)16:1<88::AID-HUMU16>3.0.CO;2-G","volume":"16","author":"US Khoo","year":"2000","unstructured":"Khoo US, Ngan HY, Cheung AN, Chan KY, Lu J, Chan VW, Lau S, Andrulis IL, Ozcelik H (2000) Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations. Hum Mutat 16:88\u201389","journal-title":"Hum Mutat"},{"key":"9708_CR46","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/humu.9015","volume":"19","author":"US Khoo","year":"2002","unstructured":"Khoo US, Chan KY, Cheung AN, Xue WC, Shen DH, Fung KY, Ngan HY, Choy KW, Pang CP, Poon CS, Poon AY, Ozcelik H (2002) Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: a founder mutation of BRCA1 identified in the Chinese population. Hum Mutat 19:307\u2013308","journal-title":"Hum Mutat"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-007-9708-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-007-9708-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-007-9708-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:28:53Z","timestamp":1559233733000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-007-9708-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,13]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["9708"],"URL":"https:\/\/doi.org\/10.1007\/s10549-007-9708-3","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,13]]}}}